Filter
704
Text search:
medicine
manufacturing
Featured
Recommendations
58
New Publications
173
Language
Document type
No document type
315
Studies & Reports
154
Guidelines
128
Manuals
45
Strategic & Response Plan
33
Fact sheets
14
Situation Updates
8
Training Material
3
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
India
33
Kenya
29
Global
24
Nigeria
19
Ghana
18
Ethiopia
17
Uganda
16
Tanzania
14
Nepal
13
South Africa
12
Bangladesh
12
Western and Central Europe
11
Sierra Leone
10
Zambia
10
Philippines
9
Liberia
8
South–East Asia Region
8
Zimbabwe
7
Rwanda
7
Malawi
7
Lesotho
7
Namibia
6
Myanmar / Burma
6
East and Southern Africa
6
Indonesia
5
Ukraine
5
West and Central Africa
5
Africa
5
USA
4
Haiti
4
Syria
4
Cambodia
4
Thailand
4
Eswatini/ Swaziland
4
Latin America and the Carribbean
4
Congo, Democratic Republic of
3
Cameroon
3
Pakistan
3
Botswana
3
Sri Lanka
3
Asia
3
Eastern Europe
3
Albania
3
Guinea
2
Senegal
2
South Sudan
2
China
2
Sudan
2
Benin
2
Yemen
2
Western Pacific Region
2
Laos
2
Tajikistan
2
Russia
2
Mauritius
2
United Kingdom
2
Côte d’Ivoire / Ivory Coast
1
Jordan
1
Afghanistan
1
Germany
1
Lebanon
1
Egypt
1
Chad
1
Mozambique
1
Brazil
1
Serbia
1
Angola
1
Madagascar
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Solomon Islands
1
Moldova
1
Australia
1
Vietnam
1
Turkmenistan
1
Maldives
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
276
Clinical Guidelines
52
Public Health
30
Pharmacy & Technologies
29
Key Resources
21
Women & Child Health
12
Capacity Building
5
Toolboxes
Pharmacy
80
AMR
76
COVID-19
56
HIV
39
Planetary Health
36
TB
28
Mental Health
21
NTDs
21
Malaria
19
NCDs
12
Global Health Education
11
Disability
10
Rapid Response
9
Conflict
8
Specific Hazards
8
Ebola & Marburg
7
2.0 Rapid Response
7
Natural Hazards
6
Caregiver
5
Health Financing Toolbox
4
Refugee
3
Cholera
1
Polio
1
Zika
1
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
DHS Working Papers No. 69
This paper uses data from the three Indian National Family Health Surveys (1992-93, 1998-99, 2005-06) to examine how the relationship between household wealth and child mortality evolved during a time of significant economic change in India. The main predictor is a new ...
This paper uses data from the three Indian National Family Health Surveys (1992-93, 1998-99, 2005-06) to examine how the relationship between household wealth and child mortality evolved during a time of significant economic change in India. The main predictor is a new ...
Guidance statement
Recommendations on contraceptive methods used by
women at high risk of HIV
Accessed online January 2019, date of publication unknown.
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
Reporting Period 2010-2011
The document contains preliminary report on all aspects of WHO’s response in the Ebola outbreak. WHO Member States will discuss the report at the sixty-eighth World Health Assembly.
The guide explains how vaccines work and answers your common questions as well as providing up-to-date information on the current approved COVID-19 vaccinations in the UK.
This guide was written in January 2021 and updated in March 2021 and is accurate at the time of publishing. Information will b
...
Compilation of country case studies and best practices. World Health Report (2010) Background Paper, 25
Report of a virtual meeting 21–23 June 2022
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S
...
This guidance covers different options for banning or phasing out a pesticide and suggests related risk reduction measures to be taken during the phase-out period. A key focus of this guidance is how to take action to manage, prevent, minimize, and communicate about identified risks during the imple
...
Access to safe, effective and quality-assured health products and technologies is crucial for achieving universal health coverage and primary health care goals. The continued growth of the aging population; increasing burden of noncommunicable diseases; growing burden of mental health issues; climat
...